Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

ClinicalTrials.gov ID: NCT06143046

Public ClinicalTrials.gov record NCT06143046. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Pregnant Women, and Safety and Immunogenicity in Infants Born to Vaccinated Mothers

Study identification

NCT ID
NCT06143046
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
ModernaTX, Inc.
Industry
Enrollment
360 participants

Conditions and interventions

Interventions

  • mRNA-1345 Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
0 Years to 40 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 14, 2023
Primary completion
May 24, 2026
Completion
May 24, 2026
Last update posted
Jun 9, 2026

2023 – 2026

United States locations

U.S. sites
22
U.S. states
11
U.S. cities
22
Facility City State ZIP Site status
SEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS Dothan Alabama 36305-7376
Abby's Research Institute Phoenix Arizona 85031-3878
Watching Over Mothers & Babies Tucson Arizona 85712
Applied Research Center of Arkansas - ClinEdge - PPDS Little Rock Arkansas 72212-4169
Matrix Clinical Research - Gardena Gardena California 90247-4956
Matrix Clinical Research - Huntington Park Huntington Park California 90255-2913
Matrix Clinical Research, Inc - Corporate Office Los Angeles California 90057-4103
Clinical Research Prime - ClinEdge - PPDS Idaho Falls Idaho 83404-5305
Bingham Memorial Hospital Pocatello Idaho 83201
Clinical Research Prime - ClinEdge - Rexburg - PPDS Rexburg Idaho 83440-5390
Velocity Clinical Research - Covington - PPDS Covington Louisiana 70433-7237
Saginaw Valley Medical Research Group LLC Saginaw Michigan 48604-9533
Boeson Research GTF - Great Falls - ERN - PPDS Great Falls Montana 59405-5316
Boeson Research KAL - Kalispell - ERN - PPDS Kalispell Montana 59901-2158
Boeson Research MSO - Missoula - ERN - PPDS Missoula Montana 59804-7401
Velocity Clinical Research (Grand Island - Nebraska) - PPDS Grand Island Nebraska 68803-4327
Velocity Clinical Research (Hastings - Nebraska) - PPDS Hastings Nebraska 68901-2615
Velocity Clinical Research (Norfolk - Nebraska) - PPDS Norfolk Nebraska 68701-7701
DM Clinical Research - Bellaire - ERN - PPDS Houston Texas 77081
Maximos OB/GYN League City Texas 77573-2681
SMS Clinical Research Mesquite Texas 75149
Maternal Fetal Diagnostics Center Salt Lake City Utah 84132-0001

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06143046, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06143046 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →